Silke Soucek
About
In The Last Decade
Silke Soucek
20 papers receiving 966 citations
Peers
Comparison fields: 5 of 72
- Hematology 655
- Molecular Biology 379
- Genetics 367
- Oncology 225
- Public Health, Environmental and Occupational Health 186
Countries citing papers authored by Silke Soucek
This map shows the geographic impact of Silke Soucek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Soucek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Soucek more than expected).
Fields of papers citing papers by Silke Soucek
This network shows the impact of papers produced by Silke Soucek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Soucek. The network helps show where Silke Soucek may publish in the future.
Co-authorship network of co-authors of Silke Soucek
This figure shows the co-authorship network connecting the top 25 collaborators of Silke Soucek. A scholar is included among the top collaborators of Silke Soucek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Soucek. Silke Soucek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 89 | |
| 3 | 64 | |
| 4 | 67 | |
| 5 | 21 | |
| 6 | 118 | |
| 7 | 115 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 23 | |
| 11 | 114 | |
| 12 | 0 | |
| 13 | 130 | |
| 14 | 1 | |
| 15 | 17 | |
| 16 | 33 | |
| 17 | Association of specific cytogenetic aberrations with mdr1 gene expression in adult myeloid leukemia and its implication in treatment outcome. | 16 |
| 18 | Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 years. | 24 |
| 19 | 94 | |
| 20 | Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis. | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.